Filing Flows

Filing Flows › Companies › Picard Medical › Cash flow

Picard Medical cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$1.4M in Q2 2026 · −$16.0M over twelve months

Operating cash flow−$1.4M
Free cash flow−$1.4M

Analysis

In Q2 2026, Picard Medical generated −$1.4M of operating cash flow. That is $1.2M more than in Q2 2025 (−$2.5M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$16.0M; the largest uses were operating cash flow ($16.0M), net borrowing (+) / repaid (−) ($150K); besides operations, cash came from shares issued ($13.7M), other financing ($2.1M); the cash balance fell by $372K.

Operating cash flow was −$1.4M against net income of −$5.7M. The largest differences: stock-based pay +$1.4M, inventory +$1.0M, payables +$612K.

Free cash flow

Picard Medical: free cash flow by quarterPicard Medical: free cash flow by quarter−$2.6MQ3 2024−$3.2MQ4 2024−$2.2MQ1 2025−$2.5MQ2 2025−$6.5MQ3 2025−$4.4MQ4 2025−$3.8MQ1 2026−$1.4MQ2 2026
Operating cash flow less capital spending.
Picard Medical: operating cash flow against capital spendingPicard Medical: operating cash flow against capital spendingOperating cash flowCapital spending−$2.6M$0Q3 2024−$3.2M$0Q4 2024−$2.2M$0Q1 2025−$2.5M$0Q2 2025−$6.5M$0Q3 2025−$4.4M$0Q4 2025−$3.8M$26KQ1 2026−$1.4M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$1.4M, Capital spending $0.

Cash runway and the debt wall

Cash & investments$38K
Debtnone
Net cash$38K
Cash runway0 months

Picard Medical is burning cash: its operations consume cash, a free cash flow of −$16.0M a year at the current rate against $38K of cash and investments: a runway of about 0 months before any new financing.

Where the cash came from and went

Picard Medical: sources (+) and uses (−) of cash, Q2 2026Picard Medical: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$1.4MOther financing$729KNet borrowing (+) / repaid (−)$500KCash drawn (+) / kept (−)$83KExchange rates$23KShares issued$17K
Picard Medical: sources (+) and uses (−) of cash, TTM to Q2 2026Picard Medical: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$16.0MShares issued$13.7MOther financing$2.1MCash drawn (+) / kept (−)$372KNet borrowing (+) / repaid (−)−$150KNot reconciled−$26KExchange rates$7K

From profit to cash

Picard Medical: net income to operating cash flow, Q2 2026Picard Medical: net income to operating cash flow, Q2 2026Net income−$5.7MDepreciation & amortization$45KStock-based pay$1.4MReceivables−$18KInventory$1.0MPayables$612KAccrued liabilities−$513KPrepaid and other assets$377KOperating cash flow−$1.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$1.4M—$500K$17K$83K−$1.4M
Q1 2026−$3.8M−$26K−$7.4M$42K$11.3M−$3.8M
Q4 2025−$4.4M—$6.0M—−$8.6M−$4.4M
Q3 2025−$6.5M—−$42K$13.7M−$2.4M−$6.5M
Q2 2025−$2.5M—$983K$985K$278K−$2.5M
Q1 2025−$2.2M—$982K$500K−$592K−$2.2M
Q4 2024−$3.2M—−$18K—−$90K−$3.2M
Q3 2024−$2.6M—$979K—$72K−$2.6M

Picard Medical: income statement and cash flow

Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%. The chart follows the revenue to costs, profit and cash.

Picard Medical: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.